These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 3614524)

  • 1. [Carbamazepine dosage and its blood serum level in children].
    Czochańska J; Losiowski Z; Prokopczyk J; Zimak J
    Neurol Neurochir Pol; 1987; 21(1):6-10. PubMed ID: 3614524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Diurnal fluctuations in plasma carbamazepine level in children with epilepsy].
    Losiowski Z; Prokopczyk J; Zimak J; Bielicka J
    Neurol Neurochir Pol; 1988; 22(3):195-200. PubMed ID: 3221956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic drug monitoring of antiepileptic drugs.
    Shakya G; Malla S; Shakya KN; Shrestha R
    JNMA J Nepal Med Assoc; 2008; 47(171):94-7. PubMed ID: 19079370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is the therapy with carbamazepine more effective when measuring blood levels?
    Tatzer E; Groh C
    Padiatr Padol; 1980; 15(4):293-6. PubMed ID: 7007988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Monotherapy with carbamazepine in childhood epilepsies].
    Dulac O; Bouguerra L; Rey E; de Lauture D; Arthuis M
    Arch Fr Pediatr; 1983 May; 40(5):415-9. PubMed ID: 6411042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose-dependency of the ratio between carbamazepine serum level and dosage in patients with epilepsy.
    Kumps AH
    Ther Drug Monit; 1981; 3(3):271-4. PubMed ID: 7324091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carbamazepine plasma levels in children and adults: influence of age, dose, and associated therapy.
    Battino D; Bossi L; Croci D; Franceschetti S; Gomeni C; Moise A; Vitali A
    Ther Drug Monit; 1980; 2(4):315-22. PubMed ID: 7222185
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinicopharmacologic study of blood carbamazepine levels in a group of epileptic patients].
    Testa G; Ermani M; Giaretta D; Pellegrini A; Paleari C
    Riv Neurol; 1980; 50(4):241-52. PubMed ID: 7466220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Therapeutic drug monitoring and the pharmacokinetics of carbamazepine in children with a convulsive syndrome].
    Kholodov LE; Prityko AG; Ivanova ES; Sokolov AV; Tishchenkova IF; Dubrovina LIu; Postnikov SS; Tatarinov PA; Kopanev IuA; Veselov NK
    Zh Nevrol Psikhiatr Im S S Korsakova; 1995; 95(3):35-40. PubMed ID: 7571921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The epoxide of carbamazepine.
    McKauge L; Tyrer JH; Eadie MJ
    Clin Exp Neurol; 1979; 16():95-104. PubMed ID: 550961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum carbamazepine concentration--dose dependency and daily fluctuations.
    Takahashi Y; Nikkuni S; Honda K; Ono T; Kumashiro H
    Folia Psychiatr Neurol Jpn; 1980; 34(3):298. PubMed ID: 7216017
    [No Abstract]   [Full Text] [Related]  

  • 12. An experimental design for finding of minimum dosage of carbamazepine and valproate in preventing of seizure attacks.
    Samaei A; Nobahar M; Vafaei AA
    Pak J Pharm Sci; 2009 Apr; 22(2):180-3. PubMed ID: 19339229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Once daily dosage versus divided daily doses of carbamazepine therapy in epileptic patients: a pilot study.
    Ghose K; Dawson M; Fry DE; Christofides JA
    Pharmatherapeutica; 1981; 3(1):71-8. PubMed ID: 7033994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Steady-state carbamazepine plasma concentration-dose ratios in epileptic patients.
    Sánchez A; Durán JA; Serrano JS
    Clin Pharmacokinet; 1986; 11(5):411-4. PubMed ID: 3780114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zonisamide monotherapy with once-daily dosing in children with cryptogenic localization-related epilepsies: clinical effects and pharmacokinetic studies.
    Miura H
    Seizure; 2004 Dec; 13 Suppl 1():S17-23; discussion S24-5. PubMed ID: 15511682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population pharmacokinetics of steady-state carbamazepine in Egyptian epilepsy patients.
    El Desoky ES; Sabarinath SN; Hamdi MM; Bewernitz M; Derendorf H
    J Clin Pharm Ther; 2012 Jun; 37(3):352-5. PubMed ID: 21883329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for carbamazepine elevation and toxicity following epilepsy surgery.
    Hiremath GK; Kotagal P; Bingaman W; Hovinga C; Wyllie E; Morris H; Nelson D
    Seizure; 2005 Jul; 14(5):312-7. PubMed ID: 15876544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship of intraindividual dose to plasma concentration of carbamazepine: indication of dose-dependent induction of metabolism.
    Tomson T; Svensson JO; Hilton-Brown P
    Ther Drug Monit; 1989 Sep; 11(5):533-9. PubMed ID: 2815227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Serum levels of vitamin B12 in epileptic patients treated with carbamazepine].
    Rościszewska D; Motta E; Guz I
    Neurol Neurochir Pol; 1993; 27(5):671-5. PubMed ID: 8114990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Replacing carbamazepine slow-release tablets with carbamazepine suppositories: a pharmacokinetic and clinical study in children with epilepsy.
    Arvidsson J; Nilsson HL; Sandstedt P; Steinwall G; Tonnby B; Flesch G
    J Child Neurol; 1995 Mar; 10(2):114-7. PubMed ID: 7782600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.